In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from ...
BioNTech , Chief Executive Ugur Sahin expects efficacy results from its late-stage trial of its potential coronavirus vaccine to be available shortly and said the company could file for U.S. approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback